This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (4)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurogenetics  • Genetic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Alexander Lossos, MD; Moona Khoury, MD; William B. Rizzo, MD; John M. Gomori, MD; Eyal Banin, MD, PhD; Abraham Zlotogorski, MD; Saleh Jaber, MD; Oded Abramsky, MD, PhD; Zohar Argov, MD; Hanna Rosenmann, PhD

Arch Neurol. 2006;63:278-280.

Background  Sjögren-Larsson syndrome (SLS) is an early childhood–onset disorder with ichthyosis, mental retardation, spastic paraparesis, macular dystrophy, and leukoencephalopathy caused by the deficiency of fatty aldehyde dehydrogenase due to mutations in the ALDH3A2 gene (the gene that encodes microsomal fatty aldehyde dehydrogenase). Cerebral proton magnetic resonance spectroscopy in those with SLS demonstrates an abnormal white matter peak at 1.3 ppm, consistent with long-chain fatty alcohol accumulation.

Objective  To define the clinical course and proton magnetic resonance spectroscopic findings of SLS in adults.

Design and Setting  Case series in a tertiary care center.

Patients  Six siblings of a consanguineous Arab family with early childhood–onset SLS who carry the 682CT mutation in the ALDH3A2 gene were reinvestigated in adulthood.

Results  The 6 affected siblings ranged in age from 16 to 36 years. All exhibited the typical clinical and imaging manifestations of SLS, but their severity markedly varied. Neurological involvement was apparently nonprogressive, and its severity showed no correlation with age. Cerebral proton magnetic resonance spectroscopy showed a lipid peak at 1.3 ppm, with decreasing intensity in the older siblings.

Conclusion  These observations document significant clinical variability and the nonprogressive neurological course of SLS in adult siblings with the same ALDH3A2 genotype, and demonstrate possible correlation of proton magnetic resonance spectroscopic changes with age, suggesting unknown pathogenic mechanisms to compensate for the responsible biochemical defect in this disease.

Author Affiliations: Department of Neurology, Agnes Ginges Center for Human Neurogenetics (Drs Lossos, Abramsky, Argov, and Rosenmann), and Departments of Radiology (Dr Gomori), Ophthalmology (Dr Banin), Dermatology (Dr Zlotogorski), and Orthopedics (Dr Jaber), Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Department of Internal Medicine, Carmel Medical Center, Haifa, Israel (Dr Khoury); and Department of Pediatrics, University of Nebraska Medical Center, Omaha (Dr Rizzo).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?